Y020-7563 Screening compound: ethyl 4-{2-[4-(diphenylmethyl)piperazin-1-yl]-6-oxo-3,4,5,6-tetrahydropyrimidine-4-amido}benzoate

Y020-7563 Screening compound: ethyl 4-{2-[4-(diphenylmethyl)piperazin-1-yl]-6-oxo-3,4,5,6-tetrahydropyrimidine-4-amido}benzoate
Y020-7563 Screening compound: ethyl 4-{2-[4-(diphenylmethyl)piperazin-1-yl]-6-oxo-3,4,5,6-tetrahydropyrimidine-4-amido}benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-7563
ethyl 4-{2-[4-(diphenylmethyl)piperazin-1-yl]-6-oxo-3,4,5,6-tetrahydropyrimidine-4-amido}benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-7563

Molecular Formula

C31H33N5O4 (C31 H33 N5 O4)

Compound Name

ethyl 4-{2-[4-(diphenylmethyl)piperazin-1-yl]-6-oxo-3,4,5,6-tetrahydropyrimidine-4-amido}benzoate

IUPAC name

ethyl 4-{2-[4-(diphenylmethyl)piperazin-1-yl]-6-oxo-3456-tetrahydropyrimidine-4-amido}benzoate

SMILES

CCOC(c(cc1)ccc1NC(C(C1)NC(N(CC2)CCN2C(c2ccccc2)c2ccccc2)=NC1=O)=O)=O

InChI

InChI=1S/C31H33N5O4/c1-2-40-30(39)24-13-15-25(16-14-24)32-29(38)26-21-27(37)34-31(33-26)36-19-17-35(18-20-36)28(22-9-5-3-6-10-22)23-11-7-4-8-12-23/h3-16,26,28H,2,17-21H2,1H3,(H,32,38)(H,33,34,37)/t26-/m1/s1

InChI Key

XYAIVYYHXYEPRZ-AREMUKBSSA-N

MDL Number (MFCD)

MFCD07404041

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

539.63

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.363

Distribution Coefficient, logD

4.158

Water Solubility, LogSw

-4.05

Polar Surface Area

85.132

Acid Dissociation Constant (pKa)

10.78

Base Dissociation Constant (pKb)

7.18

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

29.00

Y020-7563 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with Y020-7563 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-7563?
Check Price and Availability of Y020-7563, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-7563 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-7563
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-7563
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-7563 available by request